nodes	percent_of_prediction	percent_of_DWPC	metapath
Indacaterol—UGT1A1—Etoposide—testicular cancer	0.291	0.355	CbGbCtD
Indacaterol—ABCB1—Dactinomycin—testicular cancer	0.102	0.125	CbGbCtD
Indacaterol—CYP3A4—Ifosfamide—testicular cancer	0.0723	0.0882	CbGbCtD
Indacaterol—ABCB1—Vinblastine—testicular cancer	0.064	0.0781	CbGbCtD
Indacaterol—ABCB1—Cisplatin—testicular cancer	0.0587	0.0716	CbGbCtD
Indacaterol—ABCB1—Etoposide—testicular cancer	0.0576	0.0704	CbGbCtD
Indacaterol—ABCB1—Doxorubicin—testicular cancer	0.0393	0.048	CbGbCtD
Indacaterol—CYP3A4—Vinblastine—testicular cancer	0.0383	0.0468	CbGbCtD
Indacaterol—ABCB1—Methotrexate—testicular cancer	0.0381	0.0465	CbGbCtD
Indacaterol—CYP3A4—Etoposide—testicular cancer	0.0345	0.0422	CbGbCtD
Indacaterol—CYP3A4—Doxorubicin—testicular cancer	0.0236	0.0288	CbGbCtD
Indacaterol—Chronic obstructive pulmonary disease—Methotrexate—testicular cancer	0.00416	0.023	CcSEcCtD
Indacaterol—Rhinorrhoea—Cisplatin—testicular cancer	0.00268	0.0148	CcSEcCtD
Indacaterol—Infection—Carboplatin—testicular cancer	0.00262	0.0145	CcSEcCtD
Indacaterol—Chest discomfort—Etoposide—testicular cancer	0.00224	0.0124	CcSEcCtD
Indacaterol—Pneumonia—Chlorambucil—testicular cancer	0.00214	0.0118	CcSEcCtD
Indacaterol—Angina pectoris—Vinblastine—testicular cancer	0.00213	0.0118	CcSEcCtD
Indacaterol—Atrial fibrillation—Ifosfamide—testicular cancer	0.00193	0.0107	CcSEcCtD
Indacaterol—Bronchospasm—Bleomycin—testicular cancer	0.00182	0.01	CcSEcCtD
Indacaterol—Hypokalaemia—Ifosfamide—testicular cancer	0.00166	0.00919	CcSEcCtD
Indacaterol—Pneumonia—Bleomycin—testicular cancer	0.00166	0.00915	CcSEcCtD
Indacaterol—Tremor—Chlorambucil—testicular cancer	0.00156	0.00861	CcSEcCtD
Indacaterol—Bronchospasm—Ifosfamide—testicular cancer	0.00155	0.00858	CcSEcCtD
Indacaterol—Pneumonia—Dactinomycin—testicular cancer	0.00154	0.00854	CcSEcCtD
Indacaterol—Angina pectoris—Ifosfamide—testicular cancer	0.00154	0.0085	CcSEcCtD
Indacaterol—Anaemia—Chlorambucil—testicular cancer	0.00154	0.00849	CcSEcCtD
Indacaterol—Hypokalaemia—Cisplatin—testicular cancer	0.00143	0.00792	CcSEcCtD
Indacaterol—Hyperglycaemia—Ifosfamide—testicular cancer	0.00142	0.00787	CcSEcCtD
Indacaterol—Pneumonia—Ifosfamide—testicular cancer	0.00141	0.00782	CcSEcCtD
Indacaterol—Anaemia—Vinblastine—testicular cancer	0.00141	0.00778	CcSEcCtD
Indacaterol—Nasopharyngitis—Cisplatin—testicular cancer	0.00141	0.00778	CcSEcCtD
Indacaterol—Infestation NOS—Ifosfamide—testicular cancer	0.00141	0.00778	CcSEcCtD
Indacaterol—Infestation—Ifosfamide—testicular cancer	0.00141	0.00778	CcSEcCtD
Indacaterol—Vertigo—Vinblastine—testicular cancer	0.00137	0.00757	CcSEcCtD
Indacaterol—Infection—Chlorambucil—testicular cancer	0.00135	0.00745	CcSEcCtD
Indacaterol—Connective tissue disorder—Ifosfamide—testicular cancer	0.00124	0.00686	CcSEcCtD
Indacaterol—Bronchospasm—Etoposide—testicular cancer	0.00123	0.00678	CcSEcCtD
Indacaterol—Anaemia—Bleomycin—testicular cancer	0.00119	0.00657	CcSEcCtD
Indacaterol—Cardiac disorder—Ifosfamide—testicular cancer	0.00117	0.00648	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.00117	0.00647	CcSEcCtD
Indacaterol—Immune system disorder—Ifosfamide—testicular cancer	0.00114	0.00631	CcSEcCtD
Indacaterol—Mediastinal disorder—Ifosfamide—testicular cancer	0.00114	0.00629	CcSEcCtD
Indacaterol—Musculoskeletal pain—Epirubicin—testicular cancer	0.00113	0.00623	CcSEcCtD
Indacaterol—Cough—Bleomycin—testicular cancer	0.00112	0.00621	CcSEcCtD
Indacaterol—Pneumonia—Etoposide—testicular cancer	0.00112	0.00618	CcSEcCtD
Indacaterol—Paraesthesia—Vinblastine—testicular cancer	0.00112	0.00617	CcSEcCtD
Indacaterol—Infestation NOS—Etoposide—testicular cancer	0.00111	0.00614	CcSEcCtD
Indacaterol—Infestation—Etoposide—testicular cancer	0.00111	0.00614	CcSEcCtD
Indacaterol—Anaemia—Dactinomycin—testicular cancer	0.00111	0.00613	CcSEcCtD
Indacaterol—Malnutrition—Ifosfamide—testicular cancer	0.0011	0.00608	CcSEcCtD
Indacaterol—Myalgia—Bleomycin—testicular cancer	0.00109	0.00605	CcSEcCtD
Indacaterol—Chest pain—Bleomycin—testicular cancer	0.00109	0.00605	CcSEcCtD
Indacaterol—Connective tissue disorder—Cisplatin—testicular cancer	0.00107	0.00592	CcSEcCtD
Indacaterol—Infection—Bleomycin—testicular cancer	0.00104	0.00577	CcSEcCtD
Indacaterol—Musculoskeletal pain—Doxorubicin—testicular cancer	0.00104	0.00576	CcSEcCtD
Indacaterol—Myalgia—Dactinomycin—testicular cancer	0.00102	0.00565	CcSEcCtD
Indacaterol—Anaemia—Ifosfamide—testicular cancer	0.00102	0.00562	CcSEcCtD
Indacaterol—Cardiac disorder—Cisplatin—testicular cancer	0.00101	0.00559	CcSEcCtD
Indacaterol—Hypersensitivity—Chlorambucil—testicular cancer	0.000999	0.00553	CcSEcCtD
Indacaterol—Diabetes mellitus—Methotrexate—testicular cancer	0.000993	0.00549	CcSEcCtD
Indacaterol—Vertigo—Ifosfamide—testicular cancer	0.000987	0.00546	CcSEcCtD
Indacaterol—Immune system disorder—Cisplatin—testicular cancer	0.000983	0.00544	CcSEcCtD
Indacaterol—Mediastinal disorder—Cisplatin—testicular cancer	0.000981	0.00542	CcSEcCtD
Indacaterol—Infection—Dactinomycin—testicular cancer	0.000972	0.00538	CcSEcCtD
Indacaterol—Palpitations—Ifosfamide—testicular cancer	0.000971	0.00537	CcSEcCtD
Indacaterol—Pruritus—Chlorambucil—testicular cancer	0.000959	0.00531	CcSEcCtD
Indacaterol—Cough—Ifosfamide—testicular cancer	0.000959	0.0053	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Bleomycin—testicular cancer	0.000956	0.00529	CcSEcCtD
Indacaterol—Malnutrition—Cisplatin—testicular cancer	0.000947	0.00524	CcSEcCtD
Indacaterol—Paraesthesia—Bleomycin—testicular cancer	0.000942	0.00521	CcSEcCtD
Indacaterol—Dyspnoea—Bleomycin—testicular cancer	0.000936	0.00517	CcSEcCtD
Indacaterol—Chest pain—Ifosfamide—testicular cancer	0.000936	0.00517	CcSEcCtD
Indacaterol—Myalgia—Ifosfamide—testicular cancer	0.000936	0.00517	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.000929	0.00514	CcSEcCtD
Indacaterol—Diabetes mellitus—Epirubicin—testicular cancer	0.000929	0.00514	CcSEcCtD
Indacaterol—Cardiac disorder—Etoposide—testicular cancer	0.000925	0.00512	CcSEcCtD
Indacaterol—Hypersensitivity—Vinblastine—testicular cancer	0.000915	0.00506	CcSEcCtD
Indacaterol—Muscle spasms—Cisplatin—testicular cancer	0.000911	0.00504	CcSEcCtD
Indacaterol—Immune system disorder—Etoposide—testicular cancer	0.000901	0.00498	CcSEcCtD
Indacaterol—Mediastinal disorder—Etoposide—testicular cancer	0.000899	0.00497	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Dactinomycin—testicular cancer	0.000892	0.00493	CcSEcCtD
Indacaterol—Infection—Ifosfamide—testicular cancer	0.000891	0.00493	CcSEcCtD
Indacaterol—Tremor—Cisplatin—testicular cancer	0.000888	0.00491	CcSEcCtD
Indacaterol—Nervous system disorder—Ifosfamide—testicular cancer	0.00088	0.00486	CcSEcCtD
Indacaterol—Anaemia—Cisplatin—testicular cancer	0.000876	0.00484	CcSEcCtD
Indacaterol—Skin disorder—Ifosfamide—testicular cancer	0.000871	0.00482	CcSEcCtD
Indacaterol—Diabetes mellitus—Doxorubicin—testicular cancer	0.000859	0.00475	CcSEcCtD
Indacaterol—Muscle spasms—Etoposide—testicular cancer	0.000834	0.00462	CcSEcCtD
Indacaterol—Dizziness—Vinblastine—testicular cancer	0.000822	0.00454	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Ifosfamide—testicular cancer	0.000817	0.00452	CcSEcCtD
Indacaterol—Myalgia—Cisplatin—testicular cancer	0.000807	0.00446	CcSEcCtD
Indacaterol—Nausea—Chlorambucil—testicular cancer	0.000805	0.00445	CcSEcCtD
Indacaterol—Paraesthesia—Ifosfamide—testicular cancer	0.000805	0.00445	CcSEcCtD
Indacaterol—Anaemia—Etoposide—testicular cancer	0.000802	0.00444	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000801	0.00443	CcSEcCtD
Indacaterol—Dyspnoea—Ifosfamide—testicular cancer	0.0008	0.00442	CcSEcCtD
Indacaterol—Vertigo—Etoposide—testicular cancer	0.00078	0.00431	CcSEcCtD
Indacaterol—Headache—Vinblastine—testicular cancer	0.000778	0.00431	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000774	0.00428	CcSEcCtD
Indacaterol—Hypersensitivity—Bleomycin—testicular cancer	0.000773	0.00428	CcSEcCtD
Indacaterol—Infection—Cisplatin—testicular cancer	0.000768	0.00425	CcSEcCtD
Indacaterol—Nervous system disorder—Cisplatin—testicular cancer	0.000758	0.00419	CcSEcCtD
Indacaterol—Cough—Etoposide—testicular cancer	0.000757	0.00419	CcSEcCtD
Indacaterol—Tachycardia—Cisplatin—testicular cancer	0.000755	0.00417	CcSEcCtD
Indacaterol—Skin disorder—Cisplatin—testicular cancer	0.000751	0.00415	CcSEcCtD
Indacaterol—Asthma—Methotrexate—testicular cancer	0.000746	0.00413	CcSEcCtD
Indacaterol—Pruritus—Bleomycin—testicular cancer	0.000742	0.00411	CcSEcCtD
Indacaterol—Chest pain—Etoposide—testicular cancer	0.000739	0.00409	CcSEcCtD
Indacaterol—Nausea—Vinblastine—testicular cancer	0.000738	0.00408	CcSEcCtD
Indacaterol—Hypokalaemia—Epirubicin—testicular cancer	0.000735	0.00407	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000734	0.00406	CcSEcCtD
Indacaterol—Nasopharyngitis—Epirubicin—testicular cancer	0.000722	0.004	CcSEcCtD
Indacaterol—Hypersensitivity—Dactinomycin—testicular cancer	0.000721	0.00399	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Cisplatin—testicular cancer	0.000704	0.0039	CcSEcCtD
Indacaterol—Infection—Etoposide—testicular cancer	0.000704	0.00389	CcSEcCtD
Indacaterol—Asthma—Epirubicin—testicular cancer	0.000698	0.00386	CcSEcCtD
Indacaterol—Paraesthesia—Cisplatin—testicular cancer	0.000694	0.00384	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Methotrexate—testicular cancer	0.000693	0.00384	CcSEcCtD
Indacaterol—Tachycardia—Etoposide—testicular cancer	0.000691	0.00382	CcSEcCtD
Indacaterol—Dyspnoea—Cisplatin—testicular cancer	0.000689	0.00381	CcSEcCtD
Indacaterol—Skin disorder—Etoposide—testicular cancer	0.000688	0.00381	CcSEcCtD
Indacaterol—Hypokalaemia—Doxorubicin—testicular cancer	0.00068	0.00376	CcSEcCtD
Indacaterol—Angina pectoris—Epirubicin—testicular cancer	0.00068	0.00376	CcSEcCtD
Indacaterol—Pneumonia—Methotrexate—testicular cancer	0.000669	0.0037	CcSEcCtD
Indacaterol—Nasopharyngitis—Doxorubicin—testicular cancer	0.000668	0.0037	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000668	0.00369	CcSEcCtD
Indacaterol—Infestation NOS—Methotrexate—testicular cancer	0.000665	0.00368	CcSEcCtD
Indacaterol—Infestation—Methotrexate—testicular cancer	0.000665	0.00368	CcSEcCtD
Indacaterol—Rash—Bleomycin—testicular cancer	0.000662	0.00366	CcSEcCtD
Indacaterol—Dermatitis—Bleomycin—testicular cancer	0.000661	0.00366	CcSEcCtD
Indacaterol—Hypersensitivity—Ifosfamide—testicular cancer	0.000661	0.00365	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000649	0.00359	CcSEcCtD
Indacaterol—Asthma—Doxorubicin—testicular cancer	0.000646	0.00357	CcSEcCtD
Indacaterol—Paraesthesia—Etoposide—testicular cancer	0.000636	0.00352	CcSEcCtD
Indacaterol—Pruritus—Ifosfamide—testicular cancer	0.000635	0.00351	CcSEcCtD
Indacaterol—Dyspnoea—Etoposide—testicular cancer	0.000632	0.00349	CcSEcCtD
Indacaterol—Hyperglycaemia—Epirubicin—testicular cancer	0.00063	0.00348	CcSEcCtD
Indacaterol—Angina pectoris—Doxorubicin—testicular cancer	0.000629	0.00348	CcSEcCtD
Indacaterol—Pneumonia—Epirubicin—testicular cancer	0.000626	0.00346	CcSEcCtD
Indacaterol—Nausea—Bleomycin—testicular cancer	0.000623	0.00345	CcSEcCtD
Indacaterol—Infestation—Epirubicin—testicular cancer	0.000623	0.00344	CcSEcCtD
Indacaterol—Infestation NOS—Epirubicin—testicular cancer	0.000623	0.00344	CcSEcCtD
Indacaterol—Rash—Dactinomycin—testicular cancer	0.000617	0.00341	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Etoposide—testicular cancer	0.000612	0.00338	CcSEcCtD
Indacaterol—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.0006	0.00332	CcSEcCtD
Indacaterol—Dizziness—Ifosfamide—testicular cancer	0.000593	0.00328	CcSEcCtD
Indacaterol—Sinusitis—Epirubicin—testicular cancer	0.000584	0.00323	CcSEcCtD
Indacaterol—Hyperglycaemia—Doxorubicin—testicular cancer	0.000583	0.00322	CcSEcCtD
Indacaterol—Nausea—Dactinomycin—testicular cancer	0.000581	0.00322	CcSEcCtD
Indacaterol—Pneumonia—Doxorubicin—testicular cancer	0.000579	0.0032	CcSEcCtD
Indacaterol—Infestation NOS—Doxorubicin—testicular cancer	0.000576	0.00319	CcSEcCtD
Indacaterol—Infestation—Doxorubicin—testicular cancer	0.000576	0.00319	CcSEcCtD
Indacaterol—Hypersensitivity—Cisplatin—testicular cancer	0.00057	0.00315	CcSEcCtD
Indacaterol—Rash—Ifosfamide—testicular cancer	0.000566	0.00313	CcSEcCtD
Indacaterol—Dermatitis—Ifosfamide—testicular cancer	0.000565	0.00312	CcSEcCtD
Indacaterol—Cardiac disorder—Methotrexate—testicular cancer	0.000554	0.00307	CcSEcCtD
Indacaterol—Oedema peripheral—Epirubicin—testicular cancer	0.000551	0.00305	CcSEcCtD
Indacaterol—Connective tissue disorder—Epirubicin—testicular cancer	0.000549	0.00304	CcSEcCtD
Indacaterol—Sinusitis—Doxorubicin—testicular cancer	0.00054	0.00299	CcSEcCtD
Indacaterol—Immune system disorder—Methotrexate—testicular cancer	0.000539	0.00298	CcSEcCtD
Indacaterol—Mediastinal disorder—Methotrexate—testicular cancer	0.000538	0.00298	CcSEcCtD
Indacaterol—Nausea—Ifosfamide—testicular cancer	0.000533	0.00295	CcSEcCtD
Indacaterol—Hypersensitivity—Etoposide—testicular cancer	0.000522	0.00289	CcSEcCtD
Indacaterol—Malnutrition—Methotrexate—testicular cancer	0.00052	0.00288	CcSEcCtD
Indacaterol—Cardiac disorder—Epirubicin—testicular cancer	0.000519	0.00287	CcSEcCtD
Indacaterol—Oedema peripheral—Doxorubicin—testicular cancer	0.000509	0.00282	CcSEcCtD
Indacaterol—Connective tissue disorder—Doxorubicin—testicular cancer	0.000508	0.00281	CcSEcCtD
Indacaterol—Immune system disorder—Epirubicin—testicular cancer	0.000505	0.00279	CcSEcCtD
Indacaterol—Mediastinal disorder—Epirubicin—testicular cancer	0.000504	0.00279	CcSEcCtD
Indacaterol—Pruritus—Etoposide—testicular cancer	0.000501	0.00277	CcSEcCtD
Indacaterol—Rash—Cisplatin—testicular cancer	0.000488	0.0027	CcSEcCtD
Indacaterol—Dermatitis—Cisplatin—testicular cancer	0.000487	0.00269	CcSEcCtD
Indacaterol—Malnutrition—Epirubicin—testicular cancer	0.000487	0.00269	CcSEcCtD
Indacaterol—Anaemia—Methotrexate—testicular cancer	0.000481	0.00266	CcSEcCtD
Indacaterol—Cardiac disorder—Doxorubicin—testicular cancer	0.00048	0.00265	CcSEcCtD
Indacaterol—Dizziness—Etoposide—testicular cancer	0.000468	0.00259	CcSEcCtD
Indacaterol—Muscle spasms—Epirubicin—testicular cancer	0.000468	0.00259	CcSEcCtD
Indacaterol—Immune system disorder—Doxorubicin—testicular cancer	0.000467	0.00258	CcSEcCtD
Indacaterol—Vertigo—Methotrexate—testicular cancer	0.000467	0.00258	CcSEcCtD
Indacaterol—Mediastinal disorder—Doxorubicin—testicular cancer	0.000466	0.00258	CcSEcCtD
Indacaterol—Nausea—Cisplatin—testicular cancer	0.000459	0.00254	CcSEcCtD
Indacaterol—Cough—Methotrexate—testicular cancer	0.000454	0.00251	CcSEcCtD
Indacaterol—Malnutrition—Doxorubicin—testicular cancer	0.00045	0.00249	CcSEcCtD
Indacaterol—Anaemia—Epirubicin—testicular cancer	0.00045	0.00249	CcSEcCtD
Indacaterol—Rash—Etoposide—testicular cancer	0.000447	0.00247	CcSEcCtD
Indacaterol—Dermatitis—Etoposide—testicular cancer	0.000446	0.00247	CcSEcCtD
Indacaterol—Headache—Etoposide—testicular cancer	0.000444	0.00245	CcSEcCtD
Indacaterol—Chest pain—Methotrexate—testicular cancer	0.000443	0.00245	CcSEcCtD
Indacaterol—Myalgia—Methotrexate—testicular cancer	0.000443	0.00245	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.00044	0.00243	CcSEcCtD
Indacaterol—Vertigo—Epirubicin—testicular cancer	0.000437	0.00242	CcSEcCtD
Indacaterol—Muscle spasms—Doxorubicin—testicular cancer	0.000433	0.00239	CcSEcCtD
Indacaterol—Palpitations—Epirubicin—testicular cancer	0.00043	0.00238	CcSEcCtD
Indacaterol—Cough—Epirubicin—testicular cancer	0.000425	0.00235	CcSEcCtD
Indacaterol—Infection—Methotrexate—testicular cancer	0.000422	0.00233	CcSEcCtD
Indacaterol—Nausea—Etoposide—testicular cancer	0.000421	0.00233	CcSEcCtD
Indacaterol—Nervous system disorder—Methotrexate—testicular cancer	0.000416	0.0023	CcSEcCtD
Indacaterol—Anaemia—Doxorubicin—testicular cancer	0.000416	0.0023	CcSEcCtD
Indacaterol—Chest pain—Epirubicin—testicular cancer	0.000414	0.00229	CcSEcCtD
Indacaterol—Myalgia—Epirubicin—testicular cancer	0.000414	0.00229	CcSEcCtD
Indacaterol—Skin disorder—Methotrexate—testicular cancer	0.000412	0.00228	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000411	0.00228	CcSEcCtD
Indacaterol—Dry mouth—Epirubicin—testicular cancer	0.000405	0.00224	CcSEcCtD
Indacaterol—Vertigo—Doxorubicin—testicular cancer	0.000404	0.00224	CcSEcCtD
Indacaterol—Palpitations—Doxorubicin—testicular cancer	0.000398	0.0022	CcSEcCtD
Indacaterol—Infection—Epirubicin—testicular cancer	0.000394	0.00218	CcSEcCtD
Indacaterol—Cough—Doxorubicin—testicular cancer	0.000393	0.00217	CcSEcCtD
Indacaterol—Nervous system disorder—Epirubicin—testicular cancer	0.000389	0.00215	CcSEcCtD
Indacaterol—Tachycardia—Epirubicin—testicular cancer	0.000388	0.00214	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000387	0.00214	CcSEcCtD
Indacaterol—Skin disorder—Epirubicin—testicular cancer	0.000386	0.00213	CcSEcCtD
Indacaterol—Myalgia—Doxorubicin—testicular cancer	0.000383	0.00212	CcSEcCtD
Indacaterol—Chest pain—Doxorubicin—testicular cancer	0.000383	0.00212	CcSEcCtD
Indacaterol—Paraesthesia—Methotrexate—testicular cancer	0.000381	0.00211	CcSEcCtD
Indacaterol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000381	0.00211	CcSEcCtD
Indacaterol—Dyspnoea—Methotrexate—testicular cancer	0.000378	0.00209	CcSEcCtD
Indacaterol—Dry mouth—Doxorubicin—testicular cancer	0.000375	0.00207	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000366	0.00203	CcSEcCtD
Indacaterol—Infection—Doxorubicin—testicular cancer	0.000365	0.00202	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000362	0.002	CcSEcCtD
Indacaterol—Nervous system disorder—Doxorubicin—testicular cancer	0.00036	0.00199	CcSEcCtD
Indacaterol—Tachycardia—Doxorubicin—testicular cancer	0.000359	0.00198	CcSEcCtD
Indacaterol—Skin disorder—Doxorubicin—testicular cancer	0.000357	0.00197	CcSEcCtD
Indacaterol—Paraesthesia—Epirubicin—testicular cancer	0.000357	0.00197	CcSEcCtD
Indacaterol—Dyspnoea—Epirubicin—testicular cancer	0.000354	0.00196	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000343	0.0019	CcSEcCtD
Indacaterol—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000335	0.00185	CcSEcCtD
Indacaterol—Paraesthesia—Doxorubicin—testicular cancer	0.00033	0.00182	CcSEcCtD
Indacaterol—Dyspnoea—Doxorubicin—testicular cancer	0.000328	0.00181	CcSEcCtD
Indacaterol—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000317	0.00175	CcSEcCtD
Indacaterol—Hypersensitivity—Methotrexate—testicular cancer	0.000313	0.00173	CcSEcCtD
Indacaterol—Pruritus—Methotrexate—testicular cancer	0.0003	0.00166	CcSEcCtD
Indacaterol—Hypersensitivity—Epirubicin—testicular cancer	0.000293	0.00162	CcSEcCtD
Indacaterol—Pruritus—Epirubicin—testicular cancer	0.000281	0.00155	CcSEcCtD
Indacaterol—Dizziness—Methotrexate—testicular cancer	0.000281	0.00155	CcSEcCtD
Indacaterol—Hypersensitivity—Doxorubicin—testicular cancer	0.000271	0.0015	CcSEcCtD
Indacaterol—Rash—Methotrexate—testicular cancer	0.000268	0.00148	CcSEcCtD
Indacaterol—Dermatitis—Methotrexate—testicular cancer	0.000267	0.00148	CcSEcCtD
Indacaterol—Headache—Methotrexate—testicular cancer	0.000266	0.00147	CcSEcCtD
Indacaterol—Dizziness—Epirubicin—testicular cancer	0.000263	0.00145	CcSEcCtD
Indacaterol—Pruritus—Doxorubicin—testicular cancer	0.00026	0.00144	CcSEcCtD
Indacaterol—Nausea—Methotrexate—testicular cancer	0.000252	0.00139	CcSEcCtD
Indacaterol—Rash—Epirubicin—testicular cancer	0.00025	0.00138	CcSEcCtD
Indacaterol—Dermatitis—Epirubicin—testicular cancer	0.00025	0.00138	CcSEcCtD
Indacaterol—Headache—Epirubicin—testicular cancer	0.000249	0.00138	CcSEcCtD
Indacaterol—Dizziness—Doxorubicin—testicular cancer	0.000243	0.00134	CcSEcCtD
Indacaterol—Nausea—Epirubicin—testicular cancer	0.000236	0.0013	CcSEcCtD
Indacaterol—Rash—Doxorubicin—testicular cancer	0.000232	0.00128	CcSEcCtD
Indacaterol—Dermatitis—Doxorubicin—testicular cancer	0.000231	0.00128	CcSEcCtD
Indacaterol—Headache—Doxorubicin—testicular cancer	0.00023	0.00127	CcSEcCtD
Indacaterol—Nausea—Doxorubicin—testicular cancer	0.000218	0.00121	CcSEcCtD
